Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001140361-13-012373
Filing Date
2013-03-14
Accepted
2013-03-13 21:51:35
Documents
15
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 RAPTOR PHARMACEUTICAL CORP FORM 10-KT_12-31-2012 rptp_10kt_12312012.htm 10-KT 3146061
2 LIST OF SUBSIDIARIES rptp_exh21.1.htm EX-21.1 5634
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM rptp_exh231.htm EX-23.1 2722
4 CERTIFICATION OF CEO rptp_exh311.htm EX-31.1 6558
5 CERTIFICATION OF CFO rptp_exh312.htm EX-31.2 6467
6 CERTIFICATION OF CEO AND CFO rptp_exh321.htm EX-32.1 6573
7 RAPTOR-UCSD SECOND AMENDMENT TO LICENSE AGREEMENT rptp_exh1037.htm EX-10.37 195301
9 RAPTOR-HEALTHCARE ROYALTY PARTNERS LOAN AGREEMENT rptp_exb1038.htm EX-10.38 1346731
12 raptorchart.jpg GRAPHIC 48721
  Complete submission text file 0001140361-13-012373.txt   11857251

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT rptp-20121130.xml EX-101.INS 1634896
10 XBRL TAXONOMY EXTENSION SCHEMA rptp-20121130.xsd EX-101.SCH 71232
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rptp-20121130_cal.xml EX-101.CAL 53485
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptp-20121130_lab.xml EX-101.LAB 357862
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptp-20121130_pre.xml EX-101.PRE 237344
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rptp-20121130_def.xml EX-101.DEF 97240
Mailing Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949
Business Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949 415-382-1390
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

EIN.: 860883978 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-KT | Act: 34 | File No.: 000-25571 | Film No.: 13688957
SIC: 2834 Pharmaceutical Preparations